Publicacións nas que colabora con Rosario Gil Benso (12)

2021

  1. The status of egfr modulates the effect of mirna-200c on zeb1 expression and cell migration in glioblastoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-18

2020

  1. Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

    Investigational New Drugs, Vol. 38, Núm. 2, pp. 299-310

2019

  1. Characterization of a new glioblastoma cell line, GB-val4, with unusual TP53 mutation

    Human Cell, Vol. 32, Núm. 4, pp. 557-567

  2. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur

    Human Pathology, Vol. 84, pp. 105-114

2018

  1. Study of the activation of TLR receptors in neurospheres from glioblastoma cells in vitro

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii12

2017

  1. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma

    Cellular Oncology, Vol. 40, Núm. 4, pp. 389-399

  2. Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma

    Current Oncology, Vol. 24, Núm. 3, pp. e244-e250

2015

  1. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status

    Neuroscience, Vol. 297, pp. 243-251

  2. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma

    Clinical Neuropathology

2014

  1. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of ota

    Journal of Clinical Oncology, Vol. 32, Núm. 20

  2. Correlation between EGFR amplification and the expression of MicroRNA-200c in primary glioblastoma multiforme

    PLoS ONE, Vol. 9, Núm. 7

2013

  1. Genetic changes with prognostic value in histologically benign meningiomas

    Clinical Neuropathology, Vol. 32, Núm. 4, pp. 311-317